HR Execs on the Move

Medical Tracking Solutions

www.medicaltracking.com

 
Medical Tracking Solutions, a team of medical device industry experts, developed iTraycer to meet the day-to-day challenges of medical device companies. iTraycer is a comprehensive inventory management system that provides real-time tracking of medical devices and biologics – visible by part, lot, and serial numbers – from manufacturer to patient. The system`s multifunctional software facilitates communication and collaboration across the enterprise and enables companies to make critical, fact-based decisions with real-time information. And, iTraycer ensures compliance by addressing the traceability requirements of Unique Device Identification (UDI) regulations.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Solstice Medical

Solstice Medical is a Fort Wayne, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alva/Amco Pharmacal Co

Alva/Amco Pharmacal Co is a Niles, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gartman Systems

Gartman Systems is a Sheridan, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Montvale Technologies

Montvale Technologies is a Montvale, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Motif Neurotech

Motif Neurotech is a clinical-stage company leading the development of minimally invasive neuromodulation therapeutics for mental health. The company`s lead product, for treatment resistant depression (TRD), is a miniature implant that is designed to treat TRD by increasing activity in the prefrontal cortex. Studies over 20 years show stimulation of the pre-frontal cortex effectively treats treatment resistant depression without the side effects of anti-depressants. However, existing brain stimulation treatments like transcranial magnetic stimulation (TMS) can be expensive and challenging for patients to access, with daily treatments required for six weeks that may need to be repeated. Human and large animal studies show Motif`s prototype stimulates target brain areas like TMS, and the company is preparing to begin clinical trials of their first chronic implants in 2025. Motif`s implant is enabled by patent-pending wireless magnetoelectric power transfer developed at Rice University. Motif`s founders and key team members are clinical, medical device and academic experts with over 5,000 surgical procedures and decades of medical device experience.